BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37649266)

  • 1. Mechanism insights of curcumin and its analogues in cancer: An update.
    Joshi P; Verma K; Kumar Semwal D; Dwivedi J; Sharma S
    Phytother Res; 2023 Dec; 37(12):5435-5463. PubMed ID: 37649266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Curcumin and Its Derivatives as Anticancer Agents.
    Tomeh MA; Hadianamrei R; Zhao X
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin analogues and their hybrid molecules as multifunctional drugs.
    Noureddin SA; El-Shishtawy RM; Al-Footy KO
    Eur J Med Chem; 2019 Nov; 182():111631. PubMed ID: 31479974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
    Chainoglou E; Hadjipavlou-Litina D
    Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-based anti-prostate cancer agents.
    Chen QH
    Anticancer Agents Med Chem; 2015; 15(2):138-56. PubMed ID: 25594891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
    Zhao C; Liu Z; Liang G
    Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.
    Sarkar FH; Li Y; Wang Z; Padhye S
    Curr Pharm Des; 2010 Jun; 16(16):1801-12. PubMed ID: 20345353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues.
    Adeluola A; Zulfiker AHM; Brazeau D; Amin ARMR
    Eur J Pharmacol; 2021 Sep; 906():174266. PubMed ID: 34146588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review: Exploring Synthetic Schemes and Structure-activity Relationship (SAR) Studies of Mono-carbonyl Curcumin Analogues for Cytotoxicity Inhibitory Anticancer Activity.
    Bhandari SV; Kuthe P; Patil SM; Nagras O; Sarkate AP
    Curr Org Synth; 2023; 20(8):821-837. PubMed ID: 36703591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances of Curcumin Derivatives in Breast Cancer.
    Yin Y; Tan Y; Wei X; Li X; Chen H; Yang Z; Tang G; Yao X; Mi P; Zheng X
    Chem Biodivers; 2022 Oct; 19(10):e202200485. PubMed ID: 36069208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the molecular mechanistic paths describing the chemotherapeutic potential and epigenetic regulation of curcumin in lung cancer: a mini review.
    Karati D; Mukherjee S; Roy S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2715-2725. PubMed ID: 37982888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin: a boon to colonic diseases.
    Sareen R; Jain N; Pandit V
    Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art.
    Zangui M; Atkin SL; Majeed M; Sahebkar A
    Pharmacol Res; 2019 Mar; 141():343-356. PubMed ID: 30641277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin.
    Huang Y; Cao S; Zhang Q; Zhang H; Fan Y; Qiu F; Kang N
    Arch Biochem Biophys; 2018 May; 646():31-37. PubMed ID: 29596797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer.
    Paulraj F; Abas F; H Lajis N; Othman I; Naidu R
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31295798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential and limitations of curcumin as antimetastatic agent.
    Dytrych P; Kejík Z; Hajduch J; Kaplánek R; Veselá K; Kučnirová K; Skaličková M; Venhauerová A; Hoskovec D; Martásek P; Jakubek M
    Biomed Pharmacother; 2023 Jul; 163():114758. PubMed ID: 37141738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.
    Lai CS; Ho CT; Pan MH
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32486019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research.
    Steward WP; Gescher AJ
    Mol Nutr Food Res; 2008 Sep; 52(9):1005-9. PubMed ID: 18186103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
    Basnet P; Skalko-Basnet N
    Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.